Machine learning models accurately predict survival after surgery for upper tract urothelial cancer, supporting personalised follow up and adjuvant treatment decisions.
We identify six causal molecular biomarkers (e.g., CNPY4, ENTPD6, HLA-A) and eight clinical biomarkers (e.g., serum total protein) for MASLD across various independent cohorts. Serum total protein ...